Loading insider details...
Beta
Latest Form 4 (Jun 5, 2026): Grant/Award of 7,142 KROS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 5, 2026 | Keros Therapeutics, Inc. (KROS) | Grant/Award | 7,142 | n/a |
| Mar 5, 2026 | RAPT Therapeutics, Inc. (RAPT) | Tender of Shares | 4,956 | n/a |
| Feb 2, 2026 | RAPT Therapeutics, Inc. (RAPT) | Grant/Award | 4,956 | n/a |
| Jan 5, 2026 | Compass Therapeutics, Inc. (CMPX) | Grant/Award | 90,000 | n/a |
| Jun 18, 2025 | BioAtla, Inc. (BCAB) | Grant/Award | 23,500 | n/a |
| Jun 6, 2025 | Keros Therapeutics, Inc. (KROS) | Grant/Award | 5,250 | n/a |
| Jun 2, 2025 | RAPT Therapeutics, Inc. (RAPT) | Grant/Award | 257,832 | n/a |
| Apr 3, 2025 | RAPT Therapeutics, Inc. (RAPT) | Grant/Award | 61,202 | $65.0K |
| Feb 13, 2025 | Compass Therapeutics, Inc. (CMPX) | Grant/Award | 40,000 | n/a |
| Jun 14, 2024 | BioAtla, Inc. (BCAB) | Grant/Award | 16,500 | n/a |